Prenatal TCDD causes persistent modulation of the postnatal immune response, and exacerbates inflammatory disease, in 36-week-old lupus-like autoimmune SNF1 mice

Birth Defects Research Part B - Developmental and Reproductive Toxicology

Volumn 92, Issue 1, 2011, Pages 82-94

  Mustafa, Amjad ^a   Holladay, Steven ^b   Witonsky, Sharon ^a   Zimmerman, Kurt ^a   Manari, Ashley ^b   Countermarsh, Sheryl ^a   Karpuzoglu, Ebru ^b   Gogal, Robert ^b  

^a VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

Autoimmunity; Lupus nephritis; Prenatal exposure; SNF1 mouse; TCDD

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AUTOANTIBODY; CARDIOLIPIN ANTIBODY; CD1 ANTIGEN; CD19 ANTIGEN; CD23 ANTIGEN; CD5 ANTIGEN; COMPLEMENT COMPONENT C3; CONCANAVALIN A; DOUBLE STRANDED DNA ANTIBODY; GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4; SINGLE STRANDED DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ANTIGEN ANTIBODY COMPLEX; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; BODY WEIGHT; BONE MARROW CELL; CELL ACTIVATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE EXACERBATION; ENVIRONMENTAL EXPOSURE; FEMALE; FLOW CYTOMETRY; GENETIC PREDISPOSITION; GESTATION PERIOD; GESTATIONAL AGE; GLOMERULONEPHRITIS; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATION; KIDNEY; LYMPHOCYTE DIFFERENTIATION; LYMPHOPOIESIS; MALE; MESANGIUM CELL; MOUSE; NONHUMAN; PERINATAL PERIOD; PRENATAL EXPOSURE; PRIORITY JOURNAL; SPLEEN CELL; SPLEEN WEIGHT; SYSTEMIC LUPUS ERYTHEMATOSUS; THYMUS;

ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, ANTINUCLEAR; ANTIGEN-ANTIBODY COMPLEX; AUTOIMMUNITY; BODY WEIGHT; CARDIOLIPINS; CELL DIFFERENTIATION; CELL MOVEMENT; COMPLEMENT C3; CYTOKINES; FEMALE; IMMUNOGLOBULIN G; INFLAMMATION; KIDNEY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MICE; MICE, MUTANT STRAINS; ORGAN SIZE; PHENOTYPE; PRECURSOR CELLS, B-LYMPHOID; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SPLEEN; T-LYMPHOCYTES; TETRACHLORODIBENZODIOXIN;

ANIMALIA; MUS;

EID: 79751501546     PISSN: 15429733     EISSN: 15429741     Source Type: Journal    
DOI: 10.1002/bdrb.20285     Document Type: Article

References (37)

1. Batten M, Groom J, Cachero TG, et al. 2000. BAFF mediates survival of peripheral immature B lymphocytes. J Exp Med 192:1453-1466.
2. Beebe AM, Cua DJ, de Waal Malefyt R. 2002. The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS). Cytokine Growth Factor Rev 13:403-412.
3. Birnbaum LS, Tuomisto J. 1985. Non-carcinogenic effects of TCDD in animals. Food Addit Contam 17:275-288.
4. Busslinger M, Urbanek P. 1995. The role of BSAP (Pax-5) in B-cell development. Curr Opin Genetics Devel 5:595-601.
5. Carroll MC, Prodeus AP. 1998. Linkages of innate and adaptive immunity. Curr Opin Immunol 10:36-40.
6. Datta SK, Zhang L, Xu L. 2005. T-helper cell intrinsic defects in lupus that break peripheral tolerance to nuclear autoantigens. J Mol Med 83:267-278.
7. Dietert RR, DeWitt R, Germolec DR, et al. 2010. Breaking patterns of environmentally-influenced disease for health risk reduction: immune perspectives. Environ Health Perspect 118:1091-1099.
8. Duan B, Morel L. 2006. Role of B-1a cells in autoimmunity. Autoimmun Rev 5:403-408.
9. Eastcott JW, Schwartz RS, Datta SK. 1983. Genetic analysis of the inheritance of B cell hyperactivity in relation to the development of autoantibodies and glomerulonephritis in NZB × SWR crosses. J Immunol 131:2232-2239.
10. Fries JW, Mendrick DL, Rennke HG. 1988. Determinants of immune complex-mediated glomerulonephritis. Kidney Int 34:333-345.
11. Gehrs BC, Smialowicz RJ. 1999. Persistent suppression of delayed-type hypersensitivity in adult F344 rats after perinatal exposure to 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin. Toxicology 134:79-88.
12. Gehrs BC, Riddle MM, Williams WC, Smialowicz RJ. 1997. Alterations in the developing immune system of the F344 rat after perinatal exposure to 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin: II. Effects on the pup and the adult. Toxicology 122:229-240.
13. Grimaldi CM, Michael DJ, Diamond B. 2001. Cutting edge: expansion and activation of a population of autoreactive marginal zone B cells in a model of estrogen-induced lupus. J Immunol 167:1886-1890.
14. Holladay SD, Mustafa A, Gogal Jr RM. 2010. Prenatal TCDD in mice increases adult autoimmunity. Reprod Toxicol, in press.
15. Kantor AB, Merrill CE, Herzenberg LA, Hillson JL. 1997. An unbiased analysis of V(H)-D-J(H) sequences from B-1a, B-1b, and conventional B cells. J Immunol 158:1175-1186.
16. Lawrence BP, Vorderstrasse BA. 2004. Activation of the aryl hydrocarbon receptor diminishes the memory response to homotypic influenza virus infection but does not impair host resistance. Toxicol Sci 79:304-314.
17. Loder F, Mutschler B, Ray RJ, et al. 1999. B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. ExpeR Med 190:75-89.
18. Mannik M, Merrill CE, Stamps LD, Wener MH. 2003. Multiple autoantibodies form the glomerular immune deposits in patients with systemic lupus erythematosus. J Rheumatol 30:1495-1504.
19. Masten SA, Shiverick KT. 1995. The Ah receptor recognizes DNA binding sites for the B cell transcription factor, BASP: a possible mechanism for dioxin-mediated alteration of CD19 gene expression in human B lymphocytes. Biochem Biophys Res Commun 212:27-34.
20. Mohan C, Shi Y, Laman JD, Datta SK. 1995. Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. J Immunol 154:1470-1480.
21. Molina V, Shoenfeld Y. 2005. Infection, vaccines and other environmental triggers of autoimmunity. Autoimmunity 38:235-245.
22. Mustafa A, Holladay SD, Goff M, et al. 2008. An enhanced postnatal autoimmune profile in 24 week-old C57BL/6 mice developmentally exposed to TCDD. Toxicol Appl Pharmacol 232:51-59.
23. 1 mice. Toxicol Sci 112:133-143.
24. 1 mice. Birth Defects Res A Clin Mol Teratol 85:828-836.
25. Nalbandian A, Crispín JC, Tsokos GC. 2009. Interleukin-17 and systemic lupus erythematosus: current concepts. Clin Exp Immunol 157:209-215.
26. Niiro H, Clark EA. 2002. Regulation of B-cell fate by antigen-receptor signals. Nat Rev Immunol 2:945-956.
27. O'Garra A, Chang R, Go N, et al. 1992. Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10. Eur J Immunol 22:711-717.
28. Sandel PC, Monroe JG. 1999. Negative selection of immature B cells by receptor editing or deletion is determined by site of antigen encounter. Immunity 10:289-299.
29. Sater RA, Sandel PC, Monroe JG. 1998. B cell receptor-induced apoptosis in primary transitional murine B cells: signaling requirements and modulation by T cell help. Inter Immunol 10:1673-1682.
30. Sugita-Konishi Y, Kobayashi K, Naito H, et al. 2003. Effect of lactational exposure to 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin on the susceptibility to Listeria infection. Biosci Biotechnol Biochem 67:89-93.
31. Thurmond TS, Gasiewicz TA. 2000. A single dose of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin produces a time- and dose-dependent alteration in the murine bone marrow B-lymphocyte maturation profile. Toxicol Sci 58:88-95.
32. Vorderstrasse BA, Cundiff JA, Lawrence BP. 2006. A dose-response study of the effects of prenatal and lactational exposure to TCDD on the immune response to influenza a virus. J Toxicol Environ Health A 69:445-463.
33. Wang SL, Lin CY, Guo YL, et al. 2004. Infant exposure to polychlorinated dibenzo-p-dioxins, dibenzofurans and biphenyls (PCDD/Fs, PCBs)-correlation between prenatal and postnatal exposure. Chemosphere 54:1459-1473.
34. Waters ST, McDuffie M, Bagavant H, et al. 2004. Breaking tolerance to double stranded DNA, nucleosome, and other nuclear antigens is not required for the pathogenesis of lupus glomerulonephritis. Exp Med 199:255-264.
35. Wyman A, Lavin AL, Wilding GE, Gasiewicz TA. 2002. 2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin does not directly alter the phenotype of maturing B cells in a murine coculture system. Toxicol Appl Pharmacol 180:164-177.
36. Yamaguchi K, Near RI, Matulka RA, et al. 1997. Activation of the aryl hydrocarbon receptor/transcription factor and bone marrow stromal cell-dependent preB cell apoptosis. J Immunol 158:2165-2173.
37. Yoo BS, Boverhof DR, Shnaider D, et al. 2004. 2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the regulation of Pax5 in lipopolysaccharide-activated B cells. Toxicol Sci 77:272-279.